The Board resolution dated July 31, 2019, Imexpharm Corporation approved the following issues:

1. Approving the business result in first 6 months of 2019:

-          Total revenue:      564.1 billion dongs, reached 38.9% plan of 2019, increased 8.4% compared to the same period last year.

-          Profit before tax: 86.3 billion dongs, reached 39.2% plan of 2019, increased 7.7% compared to the same period last year.

1. Approving the business plan in last 6 months of 2019:

-          Total revenue:      1,450 billion dongs

-          Profit before tax:    220 billion dongs.

1. Approving to handle the bad debts with total value of VND173,288,219.
2. Approving to liquidate of the land in No.08 Le Thi Trung, Phu Loi, Thu Dau Mot, Binh Duong.